Landscapes / Companies
LigaChem Biosciences, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
3 active
8 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Jan 2027Phase 1/2 trial completes | |||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2030Phase 1/2 trial completes | |||
| Next date | Feb 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2027Phase 1 trial completes | |||
| Next date | Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Ovarian Cancer, Breast Cancer and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- Delpazolid
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021